Stock CXT CRANE NXT
Add to a list
To use this feature you must be a member
Log inSign up

Financials Crane NXT Nyse

Equities

CXT

US2244411136

Industrial Machinery & Equipment

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
62.65 USD +0.21% Intraday chart for Crane NXT +2.15% -34.95%
Apr. 26 CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2% MT
Apr. 26 CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,181 4,513 5,974 5,640 6,712 8,241 - -
Enterprise Value (EV) 1 5,778 5,180 6,338 6,225 6,631 8,204 7,871 7,785
P/E ratio 39.3 x 25.2 x 13.8 x 14 x 33.4 x 29.5 x 25.3 x 22.4 x
Yield 1.81% 2.21% 1.69% 1.87% 0.85% 0.56% 0.63% 0.73%
Capitalization / Revenue 1.58 x 1.54 x 1.88 x 1.67 x 3.22 x 3.58 x 3.37 x 3.17 x
EV / Revenue 1.76 x 1.76 x 1.99 x 1.84 x 3.18 x 3.56 x 3.22 x 3 x
EV / EBITDA 9.52 x 11.5 x 10.2 x 8.7 x 18.1 x 18.3 x 16.1 x 14.2 x
EV / FCF 17.8 x 18.8 x 15.3 x -29.6 x 43.9 x 29.8 x 25.5 x 20.5 x
FCF Yield 5.63% 5.32% 6.55% -3.37% 2.28% 3.36% 3.92% 4.88%
Price to Book 3.55 x 2.96 x 3.24 x 2.97 x 4.92 x 5.78 x 4.83 x 4.1 x
Nbr of stocks (in thousands) 59,979 58,108 58,727 56,144 56,815 57,090 - -
Reference price 2 86.38 77.66 101.7 100.4 118.1 144.4 144.4 144.4
Announcement Date 1/27/20 1/25/21 1/24/22 1/23/23 1/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,283 2,937 3,180 3,375 2,086 2,301 2,443 2,596
EBITDA 1 607.3 450.9 620.4 715.5 366.2 447.1 489.5 550
EBIT 1 493.8 323.4 500.9 596.6 330.1 397.2 449.6 496.7
Operating Margin 15.04% 11.01% 15.75% 17.68% 15.82% 17.26% 18.4% 19.13%
Earnings before Tax (EBT) 1 170.7 224.5 477.2 575.2 267 366.3 430.5 509.5
Net income 1 133.3 181 435.4 410.6 203.8 281.7 327.1 372.1
Net margin 4.06% 6.16% 13.69% 12.17% 9.77% 12.24% 13.39% 14.33%
EPS 2 2.200 3.080 7.360 7.180 3.540 4.892 5.710 6.447
Free Cash Flow 1 325.1 275.4 415 -210 150.9 275.7 308.9 380.1
FCF margin 9.9% 9.38% 13.05% -6.22% 7.23% 11.98% 12.64% 14.64%
FCF Conversion (EBITDA) 53.53% 61.08% 66.89% - 41.21% 61.66% 63.11% 69.1%
FCF Conversion (Net income) 243.89% 152.15% 95.31% - 74.04% 97.88% 94.44% 102.14%
Dividend per Share 2 1.560 1.720 1.720 1.880 1.010 0.8040 0.9093 1.055
Announcement Date 1/27/20 1/25/21 1/24/22 1/23/23 1/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 833.5 770.5 801.1 864.3 815.1 824.1 513.8 509.6 530.1 532.9 565.3 562.7 582.5 590.2 598.3
EBITDA 1 168.7 122.9 170 177.7 172.3 182.1 107.4 93.8 90 82.4 109.5 110.9 114.8 112.9 118.5
EBIT 1 139.6 93.1 141.4 145.3 143.5 153 95.1 84 80.7 74.6 96.6 99.02 102.8 100.7 106.2
Operating Margin 16.75% 12.08% 17.65% 16.81% 17.61% 18.57% 18.51% 16.48% 15.22% 14% 17.09% 17.6% 17.64% 17.06% 17.75%
Earnings before Tax (EBT) 1 131 79.8 126.3 379.4 -35 113.4 79.3 57.3 74.3 64.1 82.1 92.19 95.83 96.11 103
Net income 1 116.6 72.1 105 280.5 -59.3 106.7 61.8 45.6 55.2 49.4 64.8 70.55 73.34 72.55 79.34
Net margin 13.99% 9.36% 13.11% 32.45% -7.28% 12.95% 12.03% 8.95% 10.41% 9.27% 11.46% 12.54% 12.59% 12.29% 13.26%
EPS 2 1.960 1.220 1.810 4.930 -1.060 1.870 1.080 0.7900 0.9600 0.8600 1.120 1.225 1.287 1.262 1.383
Dividend per Share 2 0.4300 0.4300 0.4700 0.4700 0.4700 0.4700 0.4700 - - 0.1800 0.1988 0.1988 0.2038 0.2038 0.2107
Announcement Date 10/25/21 1/24/22 4/25/22 7/25/22 10/24/22 1/23/23 5/10/23 7/25/23 10/23/23 1/29/24 4/22/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 598 668 364 585 - - - -
Net Cash position 1 - - - - 81.1 37.3 370 456
Leverage (Debt/EBITDA) 0.9839 x 1.481 x 0.5864 x 0.8182 x - - - -
Free Cash Flow 1 325 275 415 -210 151 276 309 380
ROE (net income / shareholders' equity) 24.3% 15% 23% 21.9% 15.7% 19.1% 20.1% 19.8%
ROA (Net income/ Total Assets) 8.6% 4.02% 9.57% 9.24% 7.61% 11% 12.7% 13.4%
Assets 1 1,549 4,506 4,550 4,442 2,678 2,550 2,579 2,777
Book Value Per Share 2 24.40 26.30 31.40 33.90 24.00 25.00 29.90 35.20
Cash Flow per Share 2 6.500 5.260 7.880 -2.690 3.370 5.460 6.580 7.640
Capex 1 68.8 34.1 51.7 58.4 42.7 49.6 53.2 56.8
Capex / Sales 2.1% 1.16% 1.63% 1.73% 2.05% 2.15% 2.18% 2.19%
Announcement Date 1/27/20 1/25/21 1/24/22 1/23/23 1/29/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Crane NXT

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
144.4 USD
Average target price
142.4 USD
Spread / Average Target
-1.37%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Industrial Valve Manufacturing

1st Jan change Capi.
VAT GROUP AG Stock VAT Group AG
+11.20% 15.36B
WATTS WATER TECHNOLOGIES, INC. Stock Watts Water Technologies, Inc.
-3.28% 6.73B
NEWAY VALVE (SUZHOU) CO., LTD. Stock Neway Valve (Suzhou) Co., Ltd.
+35.50% 1.97B
HELIOS TECHNOLOGIES, INC. Stock Helios Technologies, Inc.
+0.49% 1.51B
SUFA TECHNOLOGY INDUSTRY CO., LTD., CNNC Stock SUFA Technology Industry Co., Ltd., CNNC
+26.34% 975M
JIANGSU SHENTONG VALVE CO., LTD. Stock Jiangsu Shentong Valve Co., Ltd.
+0.92% 845M
KITZ CORPORATION Stock KITZ Corporation
+9.29% 751M
OMEGA FLEX, INC. Stock Omega Flex, Inc.
-5.19% 675M
WUXI SMART AUTO-CONTROL ENGINEERING CO., LTD. Stock Wuxi Smart Auto-Control Engineering Co., Ltd.
-20.92% 402M
Industrial Valve Manufacturing
  1. Stock Market
  2. Equities
  3. CR Stock
  4. CXT Stock
  5. Financials Crane NXT